Risk factors for nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains

被引:25
作者
Sissolak, D
Geusau, A
Heinze, G
Witte, W
Rotter, ML
机构
[1] Univ Vienna, Inst Hyg, Dept Clin Microbiol, Sch Med, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Sch Med, A-1090 Vienna, Austria
[3] Univ Vienna, Dept Med Comp Sci, Sect Clin Biometr, A-1090 Vienna, Austria
[4] Robert Koch Inst, D-38855 Wernigerode, Germany
关键词
D O I
10.1007/s10096-001-0666-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nasal carriage is an important risk factor for Staphylococcus aureus infection, particularly in HIV-infected individuals. In this analytical cross-sectional study, a variety of probable risk factors associated with nasal carriage of Staphylococcus aureus were investigated. HIV-infected patients were examined within a larger cohort of infectious diseases patients. Staphylococcus aureus strains from HIV-infected and non-HIV-infected carriers were identified by molecular biological analysis. One hundred seventy infectious disease patients, 47 of them infected with HIV, were included. All patients were admitted to the University Hospital of Vienna, Austria, between January and July 1999. Independent significant effects on Staphylococcus aureus nasal carriage were found to be HIV status (OR 2.5, 95% CI 1.1-5.6; P=0.0303), history of operation or severe wound within 3 months prior to admission (OR 4.0. 95% Cl 1.3-13.0: P=0.0208), presence of an intravenous device within 2 weeks prior to admission (OR 10.8, 95% CI 2.0-59.4, P=0.0065), and intake of antibiotics within 2 weeks prior to hospitalisation (OR 0.2. 95% CI 0.09-0.6; P=0.0016). Molecular analysis of the Staphylococcus aureus strains revealed that the strains in both groups resembled those of healthy nonhospitalized carriers in the community.
引用
收藏
页码:88 / 96
页数:9
相关论文
共 33 条
[1]   BACTERIAL ADHERENCE TO NASAL MUCOSAL CELLS [J].
ALY, R ;
SHINEFIELD, HI ;
STRAUSS, WG ;
MAIBACH, HI .
INFECTION AND IMMUNITY, 1977, 17 (03) :546-549
[2]   NASOPHARYNGEAL CARRIAGE OF STAPHYLOCOCCUS-AUREUS AND CARRIAGE OF TETRACYCLINE-RESISTANT STRAINS ASSOCIATED WITH HIV-SEROPOSITIVITY [J].
AMIR, M ;
PAUL, J ;
BATCHELOR, B ;
KARIUKI, S ;
OJOO, J ;
WAIYAKI, P ;
GILKS, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (01) :34-40
[3]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[4]   Objective measures of allergic disease in children with human immunodeficiency virus infection [J].
Bacot, BK ;
Paul, ME ;
Navarro, M ;
Abramson, SL ;
Kline, MW ;
Hanson, IC ;
Rosenblatt, HM ;
Shearer, WT .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (05) :707-711
[5]  
BLAIR JE, 1961, B WORLD HEALTH ORGAN, V24, P771
[6]   Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86
[7]  
Claus H, 1998, ZBL BAKT-INT J MED M, V287, P105
[8]  
GANESH R, 1989, LANCET, V2, P558
[10]   Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users [J].
Holbrook, KA ;
Klein, RS ;
Hartel, D ;
Elliott, DA ;
Barsky, TB ;
Rothschild, LH ;
Lowy, FD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 16 (04) :301-306